XML 37 R22.htm IDEA: XBRL DOCUMENT v3.19.1
SHAREHOLDERS' EQUITY
12 Months Ended
Dec. 31, 2018
Text Block [Abstract]  
SHAREHOLDERS' EQUITY

NOTE 13:- SHAREHOLDERS’ EQUITY

 

 

a.

General:

Ordinary shares confer upon their holders the right to receive notice to participate and vote in general meetings of the Company, and the right to receive dividends if declared.

Dividends declared on ordinary shares will be paid in New Israeli Shekels. Dividends paid to shareholders outside Israel will be converted into U.S. dollars, on the basis of the exchange rate prevailing at the date of payment.

 

 

b.

Share repurchase:

On July 25, 2018, the Company announced an extension and increase to its share repurchase plan. Under the updated plan, the Company may repurchase up to an additional $ 2,000,000 with purchases of up to $ 325,000 a quarter.

As of December 31, 2018, the Company repurchased ordinary shares for an aggregate amount of $ 7,909,889. During 2018, 2017 and 2016 the Company repurchased 10,341,000, 9,535,992, and 12,298,434 shares for an aggregate amount of $ 1,103,865, $ 995,322 and $ 987,897, respectively.

 

 

c.

Stock Options, RSU’s and PSU’s:

In 2005, the Company adopted two new equity incentive plans, which were subsequently amended in January 2014 and in July 2018: the 2005 United States Equity Incentive Plan and the 2005 Israel Equity Incentive Plan together are referred to as the Equity Incentive Plans.

Under the Equity Incentive Plans, the Company may grant options to employees, officers and directors at an exercise price equal to at least the fair market value of the ordinary shares at the date of grant and are granted for periods not to exceed seven years. The Company grants under the Equity Incentive Plans options, Restricted Stock Units (“RSUs”) and Performance RSUs (“PSUs”) and can also grant a variety of other equity incentives. Options granted under the Equity Incentive Plans generally vest over a period of four years of employment. Options, RSUs and PSUs that are cancelled or forfeited before expiration become available for future grants. The number of PSUs granted to sales employees is equal to the amount of compensation earned (based on the employee’s level) divided by the fair value of the ordinary share at the grant date. RSUs and PSUs vest over a four year period of employment from the grant date. PSUs are subject to certain performance criteria; accordingly, compensation expense is recognized for such awards when it becomes probable that the related performance condition will be satisfied.

Under the Equity Incentive Plans, the Company’s non-employee directors receive an automatic annual option grant. Following the amendments to the Equity Incentive Plans in July 2018, commencing December 31, 2018, on December 31st of each year, the number of Reserved and Authorized Shares (as defined below) under both Equity Incentive Plans together shall be automatically reset on such date to equal 10% of the sum of (i) the number of ordinary shares issued and outstanding on such date and (ii) the number of ordinary shares reserved and authorized under the Equity Incentive Plans for outstanding awards granted under the Equity Incentive Plans as of such date (provided, however, that in no event shall the number of Reserved and Authorized Shares be less than the number of ordinary shares reserved and authorized under the Equity Incentive Plans for outstanding awards granted under the Equity Incentive Plans as of such date).

The number of “Reserved and Authorized Shares” under the Equity Plans shall equal the sum of (i) the number of ordinary shares reserved and authorized under the Equity Incentive Plans for outstanding options, RSUs, PSUs and other awards granted under the Equity Incentive Plans as of such date, and (ii) the number of ordinary shares reserved, authorized and available for issuance under the Equity Incentive Plans on such date.

 

As of December 31, 2018, the number of Reserved and Authorized Shares under the Equity Incentive Plans is as detailed below:

 

     2018   

        

       Number in  
thousands

 

Stock Options outstanding

  

 

 

 

8,542

 

 

RSU outstanding

     1,293  

PSU outstanding

     85  

Ordinary shares available for issuance under the Equity Incentive Plans

     6,610  
  

 

 

 

 

Total Reserved and Authorized Shares as of December 31, 2018

  

 

 

 

16,530

 

 

  

 

 

 

A summary of the Company’s stock option activity and related information is as follows:

 

       Options in  
thousands
    Weighted  
average
exercise
price
     Aggregate  
intrinsic
value
     2018

Outstanding at beginning of year

   13,142   $75.97    $381,022

Granted

   2,048   $109.26   

Exercised

   (6,041)   $59.16   

Forfeited

   (607)   $84.15   
  

 

 

 

  

 

Outstanding at December 31, 2018

   8,542   $95.26    101,203
  

 

 

 

  

 

Exercisable at December 31, 2018

   4,007   $87.37    70,507
  

 

 

 

  

 

The weighted average fair values at grant date of options granted for the years ended December 31, 2018, 2017 and 2016; with an exercise price equal to the market value at the date of grant were $ 30.14, $ 25.00 and $ 17.14, respectively.

The total intrinsic value of options exercised during the years 2018, 2017 and 2016 was $297,477, $ 95,707 and $ 112,989, respectively.

 

A summary of the Company’s RSUs activity is as follows:

 

     Year ended
December 31,
     2018
       Number in thousands  

Unvested at beginning of year

   893

Granted

   932

Vested

   (318)

Forfeited

   (214)
  

 

Unvested the end of the year

   1,293
  

 

The weighted average fair values at grant date of RSUs granted for the years ended December 31, 2018, 2017 and 2016 were $101.2, $ 103.5 and $ 80.73, respectively.

The total fair value of shares vested during the years 2018, 2017 and 2016 was $32,279, $35,824 and $ 22,772, respectively.

A summary of the Company’s PSUs activity is as follows:

 

     Year ended
December 31,
     2018
       Number in thousands  

Unvested at beginning of year

   175

Vested

   (65)

Forfeited

   (25)
  

 

Unvested the end of the year

   85
  

 

The weighted average fair values at grant date of PSUs granted for the year ended December 31, 2018, 2017 and 2016 were $ 0, $ 104.38 and $ 82.01, respectively.

The total fair value of shares vested during 2018 was $ 6,354, during 2017 was $ 6,241, and during 2016 was $ 3,056.

As of December 31, 2018, the Company had approximately $ 189,964 of unrecognized compensation expense related to non-vested stock options and non-vested RSU’s and PSU’s, expected to be recognized over a weighted average period of 1.96 years.

 

 

d.

Employee Stock Purchase Plan (“ESPP”):

In 1996, the Company adopted an ESPP, which was subsequently amended in 2015. According to the amendments, commencing the purchase period that begins February 1, 2017, 500,000 ordinary shares are authorized for issuance under the US ESPP and 1,000,000 ordinary shares are authorized for issuance under the rest of the world (ROW) ESPP. As of December 31, 2018, 828,441 ordinary shares had been issued under the amended ESPP plan.

Eligible employees may use up to 15% of their salaries to purchase ordinary shares but no more than 1,250 shares per participant on any purchase date. The ESPP is implemented through an offering every six months. The price of an ordinary share purchased under the ESPP is equal to 85% of the lower of the fair market value of the ordinary share on the subscription date of each offering period or on the purchase date.

During 2018, 2017 and 2016, employees purchased 308,920, 346,241 and 311,257 ordinary shares at average prices of $ 87.584, $ 73.47 and $ 66.08 per share, respectively.

In accordance with ASC No. 718, the ESPP is compensatory and as such results in recognition of compensation cost. For the years ended December 31, 2018, 2017 and 2016, the Company recognized $ 6,654, $ 6,656 and $ 5,432, respectively, of compensation expense in connection with the ESPP.

 

 

e.

Stock-Based Compensation

Stock-based compensation expense related to stock options, RSUs and PSUs is included in the consolidated statements of operations as follows (in thousands):

 

     Year ended
December 31,
     2018    2017    2016

Cost of revenues

     $ 3,545        $ 2,741        $ 2,153  

Research and development

     17,644        16,233        12,718  

Selling and marketing

     20,800        18,278        19,168  

General and administrative

     47,337        50,207        48,693  
  

 

 

 

  

 

 

 

  

 

 

 

     $     89,326        $     87,459        $     82,732